Please login to the form below

Not currently logged in
Email:
Password:

World markets data from IMS

According to IMS 2006 data, audited figures for the UK pharmaceutical market showed recovery. Having experienced a decline of 2.2 per cent in 2005, the UK expanded its market in 2006 by 4.1 per cent to USD 21bn.

According to IMS 2006 data, audited figures for the UK pharmaceutical market showed recovery. Having experienced a decline of 2.2 per cent in 2005, the UK expanded its market in 2006 by 4.1 per cent to USD 21bn.

The five major EU markets of France, Germany, Italy, Spain and the UK taken together, however, experienced slowing growth for the third year running at only 4.4 per cent, down from 4.8 per cent in 2005.

North America also strengthened its pharmaceutical market in comparison to last year, when growth was just 5.4 per cent. The impact of the first year of the Medicare Part D benefit and the resulting increase in prescribing volume led to a market increase of 8.3 per cent in 2006.

The Chinese pharma market grew a massive 12.4%, although this had slowed from 20.5 per cent in 2005, due to the government's introduction of a campaign to limit physician promotion of pharmaceuticals.

India was one of the fastest growing markets in 2006, with pharmaceutical sales increasing 17.5 per cent to USD 7.3bn, helped by lower GDP per capita income in that region.

6th August 2007

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...

Infographics